Izotropic Corp. · CSE:IZO

Izotropic — Investor Presentation

11 slides from Izotropic's investor presentation

  1. Slide 1: IzoView Breast CT Technology

    IzoView E Technology Ws : — | » Engineered for Today’s Challenges & Tomorrow’s Care Models. @& X f azorroric WWW.IZOCORP.COM in @IZOTROPICCORP OTCQB: IZOZF | CSE: 1ZO

  2. Slide 2: Disclaimer

    Disclaimer This document including links to press releases, presentations, fact sheets, and/or corporate materials including audio and video files either linked or imbedded, may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, project

  3. Slide 3: The Problem with Current Breast Imaging

    The Problem with Current Breast Imaging * Mammography and Digital Breast Tomosynthesis (“DBT”) require painful Mammography/ DBT breast compression, which distorts breast anatomy and can reduce diagnostic accuracy. ¢ Dense breast tissue significantly overlaps under compression, limits the effectivene

  4. Slide 4: Understanding Breast Density

    Understanding Breast Density B. Scattered = DenseBreast-info.org and Dr. Wendie Berg * Approximately 50% of women have dense breast tissue’. * Dense tissue appears white on mammograms- so do lesions and tumors, making cancers harder to detect. * Dense breast tissue increases the risk of both develop

  5. Slide 5: Introducing IzoView

    Introducing IzoView Engineered for Today’s Challenges & Tomorrow’s Care Models. Next-generation dedicated Breast CT system delivering true 3D imaging without painful compression. Ultra-high-resolution imaging, spatial resolution approximately 100x greater than MRI. Rapid, patient-friendly imaging wo

  6. Slide 6: How IzoView Works

    How IzoView Works The patient lies face-down on a padded tabletop, comfortably positioning their own breast in an imaging cup. No technician breast handling required. Imaging hardware circles the breast in 360° and takes up to 500 ultra-high-resolution images in “10 seconds (depending on breast leng

  7. Slide 7: Clinical Breast Images

    MAMMOGRAPHY TOMOSYNTHESIS CE-BREAST CT 2D 15°- 50° TRUE 3D, 360° x1 BREAST CT IMAGE SLICE ALL IMAGES ARE OF THE SAME BREAST. Clinical Breast Images See More Breast CT * Diagnosis: Invasive Ductal Carcinoma (IDC), 2 lesions. Clinicallmages Here ¢ Images were taken using breast CT prototype devices at

  8. Slide 8: Competitive Advantages vs. Existing Modalities

    Competitive Advantages vs. Existing Modalities ° Projected Superior Dense Breast Detection: Breast CT’s true 3D imaging eliminates tissue overlap, and may outperform Mammography, DBT, and Ultrasound in dense tissue cases. Mammography/ DBT ¢ No Painful Compression: Natural pendant breast positioning

  9. Slide 9: Technology Comparison Chart

    Technology Comparison Chart Modality True 3D Imaging Cost USD Radiation Primary Use Al Integrations Yes ey ani Yes Mammography No $55K-$80K floiwddse xray) Screening Yes Digital Breast No Yes Screening & Tomosynthesis $150K-$300K creening Y ears (15°-50") (low-dose X-ray) Diagnostic i Ultrasound (Ha

  10. Slide 10: Introducing IzoView

    Introducing IzoView Engineered for Today’s Challenges & Tomorrow’s Care Models. —<t a

  11. Slide 11: Izotropic Corp. – Advanced Imaging. Accessible Care.

    w IZOTROPIC ©» CORP OR oa Advanced Imaging. Accessible Care. ~ WWW.IZOCORP.COM ‘CQB: IZOZF | CSE: IZO info@izocorp.com | sales@izocorp.com 1-833-IZO-CORP

Izotropic — Investor Presentation on 6ix